What Is a Medicare Flex Card?

When Pam O'Neill underwent a total knee replacement, her Medicare Advantage plan picked up nearly all the costs. But one aspect of her coverage surprised her. "I get $250 per quarter to spend on ...

Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)

Ad hoc announcement pursuant to Art. 53 LR Itvisma (onasemnogene abeparvovec-brve) demonstrated improved motor function and stabilization in patients regardless of SMA treatment history in Phase III ...